← Eichor
Study identifier: NCT05865600 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Perfusion Estimation For Optimal Treatment Strategy in Chronic Coronary Syndrome

Condition: Chronic Coronary Syndrome · Myocardial Ischemia · Stable Angina  ·  Sponsor: Gødstrup Hospital

PhaseNA
Planned participants570
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

We will establish a cohort of 570 symptomatic chronic coronary syndrome patients undergoing 15O-water PET and assess their symptoms through repeated questionnaires. Two hundred patients with abnormal perfusion will be randomized to immediate or delayed referral to invasive coronary angiography with concomitant optimization of guideline-directed medical therapy with repeated 15O-water PET and questionnaires at 3 and 6 months. The primary objective is to compare the potential benefit of early invasive coronary angiography (ICA) versus guideline directed medical therapy (GDMT) on symptomatic relief defined as freedom of angina after 3 months following a positive \[15O\]H2O cardiac PET/CT in patients with symptomatic chronic coronary syndrome.

This description comes directly from the study's public registry record.

Talk to the study team

Jacob H Søby, MD  ·  61659131  ·  jasoeb@rm.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Gødstrup HospitalHerning, Central Jutland, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05865600